Skip to content

USE OF TESTOSTERONE REPLACEMENT THERAPY AFTER RADICAL PROSTATECTOMY MIGHT KILL TWO BIRDS WITH ONE STONE FROM THE PERSPECTIVE OF MEN'S HEALTH AND DISEASE CONTROL

Document Type
Publications · Journal Article
Registered DB
SCIEScopusSSCI
Journal Ranking
JCR Q4Scopus Q4
Journal
JOURNAL OF MENS HEALTH16(Specialissue1) · pp.E52 · 2020
Citation
Web of Science 2Scopus 1
FWCI (Scopus)
0
JCR IF
JCR 2019 0.25
ISSN
1875-6867

Authors

  1. Nam, Jong KilFirst authorDepartment of Urology, Pusan National University Yangsan Hospital, Yangsan, Korea
  2. Lee, Ki SooDepartments of Urology, College of Medicine, Dong-A University College of Medicine, Busan, South Korea
  3. Kim, Tae NamCorresponding authorDepartment of Urology, Biomedical Research Institute of Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea

Abstract

Testosterone plays an important role in promoting the differentiation and stimulation of prostate epithelial cells. Adding to the basic physiology of testosterone, several studies led to the dissemination of the historical androgen hypothesis that higher circulating androgen levels promote prostate cancer cell growth and make the tumor more aggressive. Whereas, the prostate saturation model accounted for the androgen sensitivity of testosterone stimulation in the prostate up to a saturation point, which occurred near the level of castration. Testosterone is related to prostate cancer metabolism in a complex manner; however, within the reference range, high or normal testosterone levels are expected to maintain benign and malignant prostate cells in a differentiated state. Accumulating evidence has suggested that testosterone replacement therapy (TRT) might prevent the development of prostate cancer and even reduce prostate cancer risk. There is no change in the clinical guidelines to be followed when considering TRT in patients with a history of prostate cancer, but it is necessary for the physician to inform patients of the positive effects of TRT on male health and prostate cancer.

Keywords

TestosteroneProstatic CancerMen's HealthCANCERRISK

Identifiers

Scopus EID
2-s2.0-85089401620
WoS UID
000579664900005